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S U M M A R Y
Objective: To identify commonly reported community-acquired organisms and antimicrobial resistance
patterns exhibited by Gram-positive and Gram-negative pathogens among pilgrims visiting emergency
care departments in Makkah.
Method: The study was designed as a retrospective audit of all patients (pilgrims) admitted to two
hospitals and residing in the city of Makkah, Saudi Arabia.
Results: Among 374 isolates, Gram-negative pathogens accounted for 280 (75%), while the remaining 94
(25%) were Gram-positive organisms. Among all isolated pathogens, the highest resistance was observed
for amoxicillin–clavulanic acid. Klebsiella pneumoniae had the highest resistance to amoxicillin–
clavulanic acid and ampicillin. Most of the organisms were sensitive to tobramycin except Acinetobacter
baumannii (n = 3, 50%), Escherichia coli (n = 4, 57%), and K. pneumoniae (n = 6, 46%).
Conclusion: Overall, a high resistance was observed for beta-lactam antibiotics. In addition, a high
resistance was noted for ceftazidime with A. baumannii species (n = 16, 77%). However, for quinolones,
the highest resistance to ciproﬂoxacin was observed for E. coli, A. baumannii, methicillin-resistant
Staphylococcus aureus, and K. pneumoniae.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
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Antimicrobial resistance is an emerging problem worldwide.
Makkah is a city of the utmost importance in the Muslim world,
and millions of pilgrims from across the globe visit every year to
perform religious rituals. These mass gatherings could potentially
make Saudi Arabia a hot spot for the spread of multidrug-resistant
(MDR) strains and the spread of antibiotic resistance around the
world.1,2 The aim of the current study was to develop a database
on the most prevalent community-acquired organisms and their* Corresponding author.
E-mail address: tahir.mehmood@monash.edu (T.M. Khan).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).resistance pattern to commonly used antimicrobials in the city of
Makkah, Saudi Arabia.
2. Methods
The study was designed as a retrospective audit of electronic
records from January to June 2015. The study was conducted at two
hospitals in the city of Makkah with the availability of all major
specialties in medicine that receive pilgrims with community-
acquired exacerbations of chronic disorders. Infections were
categorized as community-acquired in the case of a positive
culture obtained within 72 h of admission, in accordance with the
guidelines of the US Centers for Disease Control and Prevention
(CDC).3 All susceptibility testing was performed according to theociety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
A. Haseeb et al. / International Journal of Infectious Diseases 47 (2016) 92–94 93Clinical and Laboratory Standards Institute (CLSI) performance
standards (25th informational supplement, M100-S25).4
3. Results
Three hundred and seventy-four bacterial pathogens were
isolated, the majority of which were from Al-Noor Specialist
Hospital (n = 313, 83%). The most frequently isolated Gram-
negative pathogen was Escherichia coli (n = 103, 27.5%), followed
by Klebsiella pneumoniae (n = 71, 19%), Pseudomonas aeruginosa
(n = 46, 12.3%), Acinetobacter baumannii (n = 26, 7%), and Proteus
mirabilis (n = 17, 4.5%). Among Gram-positive pathogens, methi-
cillin-resistant Staphylococcus aureus (MRSA) (n = 36, 9.6%)
accounted for the highest proportion, followed by methicillin-
sensitive Staphylococcus aureus (MSSA) (n = 21, 5.6%), Streptococcus
spp (n = 20, 5.3%), Enterococcus spp (n = 11, 2.9%), and Staphylococ-
cus epidermidis (n = 6, 1.6%). Most of the pathogens were isolated
from urine samples (n = 139, 37.2%), followed by sputum (n = 95,
25.4%) and blood (n = 78, 20.9%). Details are shown in Table 1.
3.1. Resistance pattern to beta-lactam antibiotics
The resistance rates were high among Gram-negative bacteria.
E. coli (n = 38, 59%), K. pneumoniae (n = 28, 52%), and MRSA (n = 15,
75%) strains showed resistance to amoxicillin–clavulanic acid
(Table 2) . A high resistance to ampicillin was recorded for E. coliTable 1
Descriptive characteristics of the study group
Characteristics Frequency (n) Percentage (%)
Gender
Male
Female
191
183
51.0
49.0
Nationality
Saudi
Pakistani
Egyptian
Bangladeshi
Yemeni
Burmese
Nigerian
Indonesian
Indian
Other
177
30
24
15
25
20
8
13
13
49
47.3
8.0
6.4
4.0
6.7
5.3
2.1
3.5
3.5
13.1
Hospital
Ajyad Emergency Hospital
(primary care hospital)
Al-Noor Specialist Hospital
(tertiary care hospital)
61
323
16.3
86.3
Pathogens isolated
Acinetobacter baumannii
ESBL-producing Escherichia coli
Escherichia coli
Enterobacter cloacae
Enterococcus spp
Klebsiella pneumoniae
MRSA
Streptococcus spp
MSSA
Pseudomonas aeruginosa
Proteus mirabilis
Staphylococcus epidermidis
Salmonellae
26
4
103
9
11
71
36
20
21
46
17
6
4
7.0
1.1
27.5
2.4
2.9
19.0
9.6
5.3
5.6
12.3
4.5
1.6
1.1
Specimen type
Blood
Urine
Sputum
Swab
Other
78
139
95
54
8
20.9
37.2
25.4
14.4
2.1
ESBL, extended-spectrum beta-lactamase; MRSA, methicillin-resistant Staphylo-
coccus aureus; MSSA, methicillin-sensitive Staphylococcus aureus.(n = 66, 84%), as well as for K. pneumoniae (n = 55, 94%), MRSA
(n = 17, 78%), and P. mirabilis (n = 14, 88%). In addition, P. aeruginosa
(n = 9, 36%) also showed resistance to ceftazidime. Both Gram-
positive and Gram-negative bacteria showed high resistance to
ceftazidime, with A. baumannii species having the highest rate
(n = 16, 77%). However, Gram-negative bacteria, with the excep-
tion of Enterobacter spp, were noticed to have high resistance to
penicillin.
3.2. Resistance among isolated pathogens to aminoglycosides and
ﬂuoroquinolones
With regard to the three most commonly used aminoglycoside
antibiotics (amikacin, gentamicin, and tobramycin), E. coli
(extended-spectrum beta-lactamase (ESBL)-positive) was ob-
served to have the highest resistance to amikacin (n = 16, 67%).
For gentamicin, P. mirabilis (n = 12, 75%) was noted to have high
resistance. Details are given in Table 2. Most Gram-negative
organisms were highly resistant to quinolones, except Salmonella
Typhi. The highest resistance to ciproﬂoxacin was observed for E.
coli (n = 57, 60%), A. baumannii (n = 19, 83%), MRSA (n = 15, 63%),
and K. pneumoniae (n = 26, 41%), as shown in Table 2. Interestingly,
A. baumannii, E. coli and K. pneumoniae were noticed to be highly
resistant to levoﬂoxacin.
4. Discussion
Three hundred and seventy-four pathogenic bacteria were
isolated in two different hospitals in the city of Makkah. Gram-
negative bacteria accounted for 280 (75%) of the total isolates, while
the remaining 94 (25%) were Gram-positive organisms. Among
Gram-negative bacteria, E. coli was the most frequently occurring
organism, followed by K. pneumoniae and P. aeruginosa. There are
several possible reasons for the development of resistance.
To date this is the perhaps the ﬁrst study to address antibiotic
susceptibility in relation to pilgrims within the ﬁrst 72 h of
admission to emergency departments. Overall it was noted that
among the Gram-positive strains, MSSA and Enterococcus spp were
the most commonly found organisms in the present study; this is
somewhat in line with the results of other studies reporting
antibiotic resistance in the Saudi region.5 In contrast, MRSA was
the second most prevalent organism in this study and its resistance
pattern against many beta-lactam and non-beta-lactam antibiotics
was variable. The resistance pattern is correlated with that of a
previous study, in which the author reported a 40% resistance rate
to oxacillin.5 Moreover, a higher resistance rate to gentamicin and
tetracycline was observed. Overall, the pattern of susceptibility to
antibiotics in the present study revealed that most of the
commonly reported organisms were resistant to beta-lactam
antimicrobials, suggesting a dire need to optimize and scrutinize
the usage of antibiotics at the emergency centres when managing
community-acquired infections among pilgrims from different
parts of world.2
In conclusion, E. coli and MRSA were two common isolates
resistant to most of the antibiotics. Overall, a high resistance was
observed for beta-lactam antibiotics. In addition, a high resistance
to ceftazidime was seen for A. baumannii species (n = 16, 77%).
However, for quinolones, the highest resistance to ciproﬂoxacin
was observed for E. coli, A. baumannii, MRSA, and K. pneumoniae.
Funding: The Deanship of Scientiﬁc Research and the Institute of
Scientiﬁc Research and Revival of Islamic Heritage at Umm Al Qura
University, Kingdom of Saudi Arabia, funded this study.
Ethics approval: This study was initially approved by the Ethics
Committee of the Faculty of Medical Sciences at Umm Al Qura
University with reference number AMSEC 15-26-12. Further
approval was obtained from the Directorate General of Health,
Table 2
Resistance patterns of different pathogens to different antibioticsa
Drugs A. baumannii ESBL E. coli E. coli E. cloacae K. pneumoniae MRSA Streptococcus
spp
MSSA P. aeruginosa P. mirabilis Salmonella
Amox/Clav NR NR 38 (59%) 5 (84%) 28 (52%) 15 (75%) 0 4 (29%) NR 6 (50%) 0
Ampicillin 3 (100%) NR 66 (84%) 6 (75%) 55 (94%) 17 (78%) NR 10 (91%) 3 (75%) 14 (88%) NR
Aztreonam NR NR 16 (49%) NR 4 (23%) 5 (72%) NR 0 NR NR NR
Cefazolin NR NR 8 (40%) NR 8 (43%) 5 (84%) NR 0 NR NR NR
Cefepime 13 (77%) NR 16 (41%) NR 8 (27%) 3 (60%) NR NR 13 (34%) 4 (58%) 0
Cefoxitin NR 0 16 (24%) 7 (100%) 10 (20%) 3 (30%) 3 (75%) 0 0 3 (23%) NR
Cefuroxime NR NR 10 (45%) 0 8 (35%) 4 (80%) NR 0 NR NR 0
Ceftazidime 16 (77%) NR 20 (34%) NR 11 (24%) 4 (50%) NR NR 9 (36%) 7 (70%) 0
Cefotaxime 18 (100%) NR 8 (31%) 0 6 (23%) 3 (60%) NR 0 18 (95%) NR 0
Ceftriaxone NR NR NR 0 0 4 (67%) 0 NR NR 0 NR
Cephalothin NR NR 29 (97%) 4 (100%) 12 (67%) 13 (87%) 5 (36%) 0 NR 6 (100%) NR
Ertapenem 0 0 NR 0 3 (13%) 0 NR 0 NR NR 0
Imipenem 9 (90%) 0 3 (3.0%) NR 5 (82%) 10 (50%) 0 3 (43%) 5 (11%) 0 0
Meropenem 9 (64%) 0 NR 0 3 (10%) NR 0 0 3 (17%) 0 0
Oxacillin NR NR NR NR NR NR NR 4 (24%) NR NR NR
Penicillin G NR NR NR NR NR 10 (91%) 3 (20%) 8 (89%) NR NR NR
Pip/Taz 0 NR NR 0 3 (17%) NR NR NR 4 (33%) 0 NR
Ticarcillin NR NR NR NR NR NR NR NR 10 (59%) NR NR
Mezlocillin 6 (100%) NR 3 (100%) NR NR NR NR NR 3 (100%) NR NR
Amikacin 16 (67%) 3 (75%) 6 (7%) NR 3 (5%) NR 0 NR 5 (12%) 5 (34%) NR
Gentamicin 11 (46%) 3 (75%) 22 (28%) 3 (50%) 24 (38%) 10 (42%) NR NR* 9 (21%) 12 (75%) NR
Tobramycin 3 (50%) NR 4 (57%) 0 6 (46%) NR NR NR 0 0 NR
Ciproﬂoxacin 19 (83%) 3 (75%) 57 (60%) 4 (45%) 26 (41%) 15 (63%) NR 4 (40%) 13 (49%) 9 (60%) 0
Levoﬂoxacin 4 (67%) NR 4 (100%) NR 4 (44%) 0 NR 0 0 NR 0
Moxiﬂoxacin NR NR 19 (6 3%) NR 16 (55%) 5 (42%) NR 4 (40%) 3 (100%) NR 0
Nalidixic acid NR NR 9 (75%) 0 NR NR NR NR NR NR NR
Norﬂoxacin NR NR 8 (44%) 0 0 NR 3 (100%) 0 0 0 NR
ESBL, extended-spectrum beta-lactamase-producing; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; Amox/Clav,
amoxicillin–clavulanic acid; Pip/Taz, piperacillin–tazobactam.
a Only resistant culture numbers and percentages are presented in the table; when only one or two samples are resistant then the results are not reported (NR).
A. Haseeb et al. / International Journal of Infectious Diseases 47 (2016) 92–9494Ministry of Health, Makkah region with reference number 47/300/
43149 based on ethical approval from the Al-Noor Specialist
Hospital Ethics Review Board.
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